Data Presented at Two Global Medical Congresses Reinforce Benefit of Enbrel (etanercept) for Patients with Chronic Inflammatory Conditions - Drugs.com MedNews
Links shared publicly online about this topic.
- 267total visits
Data Presented at Two Global Medical Congresses Reinforce Benefit of Enbrel (etanercept) for Patients with Chronic Inflammatory Conditions - Drugs.com MedNews
View full resource at drugs.com
Tags: Arthritis, Rheumatoid Arthritis, Rheumatoid Arthritis Medication, Ankylosing Spondylitis, Drug, Enbrel, Medical
Most Recently Shared on May 25, 2011 at 4:11 pm By:
Data Presented at Two Global Medical Congresses Reinforce Benefit of Enbrel (etanercept) for Patients with... http://bit.ly/iNifhs #drug
Data Presented At Two Global Medical Congresses Reinforce Benefit Of Enbrel® (etanercept) For Patients With Chronic Inflammatory Conditions
medicalnewstoday.com — “Amgen (NASDAQ: AMGN) and Pfizer Inc. (NYSE: PFE) announced new results from multiple studies of ENBREL, further expanding the body of evidence supporting the efficacy and safety profile of ENBREL,” View full resource at medicalnewstoday.com
Most Recently Shared on May 31, 2011 at 7:05 am By:
MNT Bones/Orthopedic Health News
Data Presented At Two Global Medical Congresses Reinforce Benefit Of Enbrel® (etanercept) For Patients With Chroni... http://mnt.to/3WwT
Advertisement
